| 1 |
34445158 | Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers. | 2021 Aug 6 |
4 |
| 2 |
34966254 | Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination - A Preclinical Study in Model Mice. | 2021 |
2 |
| 3 |
28870519 | Sigma-1 receptor knockout increases α-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra. | 2017 Nov |
1 |
| 4 |
27020329 | Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers. | 2016 May |
1 |
| 5 |
24507091 | Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial. | 2014 Mar |
1 |
| 6 |
18695506 | Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy. | 2008 Aug 27 |
3 |